Culbertson A N & Co. Inc. Has $471,000 Position in The Clorox Company $CLX

Culbertson A N & Co. Inc. lessened its stake in The Clorox Company (NYSE:CLX) by 74.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,824 shares of the company’s stock after selling 11,043 shares during the period. Culbertson A N & Co. Inc.’s holdings in Clorox were worth $471,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Invesco Ltd. raised its position in shares of Clorox by 138.3% during the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after acquiring an additional 1,883,465 shares during the last quarter. Norges Bank acquired a new stake in Clorox in the second quarter worth about $190,429,000. Arrowstreet Capital Limited Partnership increased its position in Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after purchasing an additional 856,873 shares during the period. Worldquant Millennium Advisors LLC bought a new stake in Clorox during the 2nd quarter worth about $71,856,000. Finally, Nuance Investments LLC lifted its position in Clorox by 182.5% during the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock valued at $101,832,000 after purchasing an additional 547,839 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber bought 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX opened at $106.20 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $164.22. The company has a fifty day simple moving average of $103.00 and a 200 day simple moving average of $115.62. The stock has a market cap of $12.95 billion, a P/E ratio of 16.67, a P/E/G ratio of 0.53 and a beta of 0.58.

Clorox (NYSE:CLX) last posted its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same period in the previous year, the company posted $1.86 earnings per share. The company’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.7%. Clorox’s payout ratio is currently 77.86%.

Analyst Ratings Changes

Several equities research analysts have recently commented on CLX shares. Jefferies Financial Group reiterated a “buy” rating and set a $152.00 price target on shares of Clorox in a research report on Tuesday, November 4th. JPMorgan Chase & Co. lowered their target price on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. UBS Group set a $119.00 price target on Clorox and gave the company a “neutral” rating in a research note on Tuesday, November 4th. Morgan Stanley reduced their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. Finally, TD Cowen dropped their price objective on Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a report on Thursday. One equities research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $122.88.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.